• Haemocompatibility testing of polymers by thromboelastography
• Thrombelastography (TEG) shows more rapid clot formation and polymerisation in woman taking hormone supplements
• Effect of treatment with recombinant factor VIIa (NovoSeven) or activated prothrombin complex concentrate (Feiba) on blodd coagulation system
• Hemostatic changes in patients receiving hydroxyethyl starch: the influence of ABO blood group
• Monitoring blood clot polymerisation inhibition by hydroxyethyl starch via extrinsic activated thrombelastography
• The effect of the combined administration of colloids and Ringer's Lactate on the coagulation system - an in vitro study using thrombelastography (roTEG)
• Emergency use of recombinant factor VIIa in life threatening haemorrhagia in patients on oral anticoagulation therapy. Monitoring of the efficacy by a novel whole blood teg principle from whichvelocity profiles of clotting can be established
• Emergency use of NovoSeven in life-Threating haemorrhagia in patients on oral anticoagulation therapy: Monitorung of efficacy by a novel whole blood TEG principle from which velocity and acceleration profiles of clotting can be established 6th Novo N
• Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight
• The effect of hydroxyethyl starch 200 kD on platelet function
• Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation
• Management and monitoring of recombinant activated factor VII
• Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists
• Synergistic interactions between the low molecular weight heparin (LMWH) tinzaparin & different platelet GPIIb/IIIa antagonists: potential implication in thromboembolic disorders
• Comparative efficiacy between different low molecular weight heparin (LMWH) and various molecular weight distribution fractions in inhibiting platelet-fibrin clot retraction under shear-mediated by tissue factor and endotoxin using TEG
• Differential behavior of anti-Xa adjusted low molecular weight heparins in native whole blood analysis as performed by thromboelastography and activated clotting time
• Heparinase is capable of neutralizing the anticoagulant and hemorrhagic effects of a synthetic pentasaccharide
• Influence of fibrinogen concentration and platelet count on extrinsic activated thrombelastography (ExTEG)
• Monitoring of recombinant factor VIIa (NovoSeven) therapy
• In-vitro Effekt von c7E3-Fab und Cytochalasin D in der Thrombelastographie
• c7E3-Fab (Abciximab, ReoPro(R)) kann den Einfluss der Thrombozyten im TEG nicht vollständig eliminieren
• Monitoring of platelet concentrates during storage by flow cytometry, aggregometry, resonance thrombography and rotational thrombelastography
• c7E3-Fab (Abciximab, ReoPro®) kann den Einfluss der Thrombozyten im TEG nicht vollständig eliminieren
• Citrate Anticoagulation for Extracorporeal Circuits: Effects on Whole Blood Coagulation Activation and Clot Formation
• Assay Analysis on a hemophilia A patient with inhibitors under factor VIIa therapy
• The Influence of Intravascular Volume Therapy with a New Hydroxyethyl Starch Preparation (6% HES 130/0.4) on Coagulation in Patients Undergoing Major Abdominal Surgery
• Die Kollagen-induzierte Plättchenaktivierung im Vollblut beeinflusst die mittels Thrombelastographie bestimmte Gerinnselbildung
• Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation
• Potential role of the dynamic properties of whole blood coagulation in assessment of dosage requirements in haemophilia

18th ISTH; July 6-12; 2001: P2925
Stemberger M, Stemberger A,Calatzis A,Ibrahim K,Kohn J

Plastic Materials
Haemocompatibility

To top

18th ISTH; July 6-12; 2001: P1461
Hall D, Mallett S, Royston D, Thornton M

Hypercoagulation
Steroid hormons

To top

Thrombosis Haemostasis;2001; P601
Geisen U, Keller F, Grossmann R, Schambeck CM

rF VII a
FEIBA

To top

Anesth Analg. 2001 Jun; 92(6):1396-401
Huraux C, Ankri A A, Eyraud D, Sevin O, Menegaux F, Coriat P, Samama CM

AB0 blood group
HES

To top

Proceedings of the 16th international Congress of Clinical Chemistry, London 1996
Calatzis An., Hipp R., Mößmer G., Stemberger A.

HES
Polymerisation disorders

To top

Critical Care, 2001, vol..5, suppl..1
Fries D., Innerhofer P., Klingler A., Berresheim U., Calatzis A., Schobersberger W.

Plasma expander
Gelatine
HES

To top

34th Nordisk Coagulation Meeting, Göteborg 7-9 Juni 2001
Sorensen B, Johansen P, Sorensen JC, Ingerslev J

Oral anticoagulation
rF VIIa
Novo Seven^®

To top

Copenhagen - Denmark 3-4 May 2001
Sorensen b, Johansen P, sorensen JC, Ingerslev J

RF VIIa
Oral antcoagulation
Novo Seven^®

To top

Acta Anaesthesiol Scand. 2000; Oct;44(9):1116-21
Entholzner EK, Mielke LL, Calatzis AN, Feyh J, Hipp R, Hargasser SR

HES

To top

Anesth Analg. 2000 Oct;91(4):823-7
Stogermuller B, Stark J, Willschke H, Felfernig M, Hoerauf K, Kozek-Langenecker SA

HES
HES 200
Celite modified TEG^®
PFA-100^®
Platelet function
GPIIb/IIIa

To top

Am J Clin Pathol. 2000 May;113(5):725-31
Zmuda K, Neofotistos D, Ts'ao CH

UFH
Heparin
LMWH
Danaparoid
Heparinase

To top

Blood Coagul Fibrinolysis. 2000; Apr;11 Suppl 1:S25-30.
Ingerslev J, Christiansen K, Calatzis A, Holm M, Sabroe Ebbesen L.

rF VII a
Novo Seven^®
Haemophilia
Inhibitors

To top

Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1162-7
Mousa SA, Khurana S, Forsythe MS

Platelet glycoprotein IIb/IIIa antagonists binding kinetics integrins
Tissue factor

To top

Blood 2000, ASH
Mousa S., Forsythe M.

Heparin
Low-molecular-weight
Tissue factor pathway inhibitor

To top

Blood 2000, ASH
Mousa S., Forsythe M., Larnkjaer A., Johansen K.

Tissue factor
Heparin
LMWH

To top

Blood 2000, ASH
Iqbal O., Hoppenstaedt D., Lewis B., Leya F., Ma Q., Fareed J.

Heparin
Low-molecular-weight
Coagulation tests

To top

Blood 2000, ASH
Iqbal O., Shadid H., Silver P., Walenga J., Daud A., Ahmad S., Fareed J.

Heparinase
Pentasaccharide

To top

Anesth Analg 1997;84:S230
Calatzis An.,Calatzis Al.,Kling M., Entholzner E.,Stemberger A.,Hipp R.

Fibrinogen
Platelet function
Platelet count

To top

U. Friedrich, L. Tengborn, U. Hedner
Novo Nordisk Symposium "World Federation Haemophilia Congress", Sevilla 19-24 May, 2002

r F VIIa
Novo Seven (R)
Haemophilia

To top

Lang T., Toller W., Gütl M., Mahla E., Freisinger F., Metzler H., Halwachs-Baumann G.
Klinisches Institut f. Med. u. Chem. Labordiagnostik, LKH-Universitätsklinikum Graz, Österreich
Wiener Klin. Wschr. 2002, 114 (Suppl. 4): 124

Platelet Count
FIBTEM

To top

Lang T., Toller W., Rehak P.H., Gütl M., Mahla E., Metzler H., Halwachs-Baumann G.
Klinisches Institut f. Med. u. Chem. Labordiagnostik, LKH-Universitätsklinikum Graz, Österreich
Wiener Klin. Wschr. 2002, 114 (Suppl. 4): 13

Fibrinogen
FIBTEM

To top

Geidel K., Brockmann M.-A., Magens M.M., Siemensen M., Duka F., Kuehnl P., Gutensohn K.
Department of Transfusion Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Infus Ther Transfus Med 2001; 28: (Sonderheft 1): 1-70

Platelet Concentrates

To top

Lang T., Toller W., Rehak P.H., Gütl M., Mahla E., Metzler H., Halwachs-Baumann G.
Klinisches Institut f. Med. u. Chem. Labordiagnostik, LKH-Universitätsklinikum Graz, Österreich

Reo Pro
Fibrinogen

To top

Calatzis A., Toepfer M., Schramm W., Spannagl M., Schiff H.
Divisions of Hemostaseology and Nephrology, Med. Klinik Innenstadt, Ludwig Maximillians University, Munich, Germany
Nephron 2001; 89:223-236

Citrate Anticoagulation
Ecarin

To top

Friedrich U., Tengborn L., Hedner U.
Novo Nordisk A/S, Copenhagen, Denmark, Sahlgrenska Hospital, Gothenburg, Sweden

F VIIaNovo SevenHaemophiliaInhibitors

To top

Haisch G., Boldt J., Krebs C., Kumle B., Suttner St., Schulz A.
Anesth. Analg 2001, 92: 565-71

HES

To top

Krause S., Scholz Th., Temmler U., Lösche W.
Friedrich-Schiller-Universität Jena, Zentrum f. Vaskuläre Biologie und Medizin Erfurt

Platelet function
Collagen

To top

Sørensen B., Johansen P., Christiansen K., Woelke M., Ingerslev J.
Journal of Thrombosis and Haemostasis, Vol.1, Issue 3, 3/2003

Novo Seven
Factor VIIa
Haemophilia
Oral anticoagulation

To top

Ingerslev J., Poulsen L. H., Sørensen B.
Haemophilia (2003), 9, 348-352

Haemophilia
F VIII
F VIII concentrates
Dosaging of F VIII concentrates
B domainless F VIII
diluted tissue factor

To top